Skip to main content
Eli Lilly to invest $400M to expand manufacturing facilities
11/21/2019

Eli Lilly and Co. announced plans to spend $400 million for the expansion of its manufacturing capabilities at its Indianapolis campus. The expansion project will include added capacity for its diabetes medicines, improvements to its current facilities that produce insulin, and initial capital investments for future drugs and therapies to be developed.

Full Story: